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Abstract: Phytochemical investigation of the aerial parts of Dodonaea viscosa led to the isolation of six new compounds including 
four isoprenylated flavonoids, dodovisones A–D (1–4), and two clerodane diterpenoids, dodovislactones A and B (5 and 6). Their 
structures were established by extensive spectroscopic analysis. 
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Introduction 
The genus Dodonaea (Sapindaceae) is composed of  
approximately 50 species and is mainly distributed throughout 
Australia and its nearby islands. Only one species exists in 
China, Dodonaea viscosa; a eurytopic species growing 
throughout the tropics and sub-tropics.1 This plant has been 
used as a folk medicine for the treatment of fever, skin diseases,
stranguria, toothache, rheumatism, gout, inflammation, and 
swelling.2,3 Previous chemical investigations of D. viscosa 
found flavonoids, diterpenoids, triterpenoid saponins,  
cyanolipids, and phenylpropanoids, among which isoprenylated
flavonoids and clerodane diterpenoids predominated.2–7  
Pharmacological studies on the title plant have shown  
bioactivities such as antibacterial8 and antioxidant8 activities, 
inhibition against urease9 and enoyl-ACP reductase,10 and 
activity against liver fibrosis.11 Hou et al. reported that some 
isoprenylated flavonoids from this plant enhanced the  
accumulation of lipid droplets significantly and induced the 
up-regulation of the expression of the adipocyte-specific genes 
aP2 and GLUT4.2 Recent pharmacological research on  
hautriwaic acid and related terpenes derived from this plant 
also displayed potent inhibitions against edema-associated 
inflammation which were similar or higher than those of  
reference compound indomethacin when evaluated in the 
chronic test.12 
As part of our effort to assemble a large-scale natural  
compound library of thousands of structures as well as to  
examine opportunities for the development of natural  
resources,13 the study described herein was undertaken to  
determine the chemical constituents in the aerial parts of D. 
viscosa. The resulting investigation characterized four  
isoprenylated flavonoids, dodovisones A–D (1–4), as well as 
two clerodane diterpenoids, dodovislactones A and B (5 and 6), 
together with 12 known compounds: dodoviscin J,2 dodoviscin 
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olid-18-oic acid;19 and hautriwaic acid.20 Herein, we describe 
the isolation and structure elucidation of the new compounds. 
 
Results and Discussion 
Compound 1 was isolated as a yellowish powder with a  
molecular formula of C27H30O8, as evidenced by HREIMS at 
m/z 482.1960 (calcd 482.1941) and NMR spectroscopic data, 
with 13 degrees of unsaturation. The IR spectrum suggested 
the presence of hydroxy (3417 cm–1) and conjugated carbonyl 
(1656 cm–1) groups in 1. The UV spectrum (MeOH) of 1 
showed maxima at 251, 271, and 352 nm suggestive of a  
flavone nucleus and also closely reflecting the UV absorbances
of related flavones isolated from the same species2. The 1H 
NMR spectrum (Table 1) displayed a chelated phenolic  
hydroxy group at δH 12.94 (1H, br, s), an aromatic proton at δH 
6.55 (1H, s), two meta-coupled aromatic protons at δH 7.66 
and 7.76 (each 1H, d, J = 1.7 Hz), and two methoxy groups at 
δH 3.83 and 4.03 (each 3H, s). The 1H NMR data also  
exhibited two isoprenoid units: a 2,2-dimethyl-3-hydroxy-
dihydropyran ring21 [δH 1.41 and 1.36 (each 3H, s), 3.88 (1H, 
dd, J = 5.5, 4.8 Hz), 2.87 (1H, dd, J = 16.7, 5.5 Hz), and 3.16 
(1H, dd, J = 16.7, 4.8 Hz)] ; and a 3-methyl-2-butenyl group2 
[δH 1.74 and 1.76 (each 3H, s), 5.31 (1H, t, J = 7.5 Hz), and 
3.36 and 3.32 (each 1H, dd, J = 15.5, 7.5 Hz)]. The 13C NMR 
(Table 1) spectrum showed 27 carbon signals corresponding to 
a flavonol derivative with two isoprenoid moieties and two 
methoxy groups. The presence of the dihydropyran ring was 
further supported by the HMBC correlations (Figure 1) from 
H-1′′ to C-2′′ and C-3′′, and from H-5′′ to C-2′′, C-3′′, and C-4′′. 
Given that no correlation was observed for H-2′′ to C-4′, weak 
correlation from H3-4′′ to C-4a (4J) strongly suggested that an 
oxygen atom was to bridge C-4′ (δC 153.2) and C-3′′ (δC 77.2) 
and not C-4′ and C-2′′. This unit was fused to ring B as shown 
via C-3′ and C-4′ by the HMBC correlations from H-1′′ to C-2′, 
C-3′, and C-4′. Another isoprenoid unit was confirmed by 
HMBC correlations from H-2′′′ to C-1′′′, C-4′′′, and C-5′′′, and 
from H-1′′′ to C-2′′′ and C-3′′′ and was attached to C-5′ by  
correlations from H2-1′′′ to C-4′, C-5′, and C-6′. During our 
work to elucidate hundreds of structures of aromatic methoxy-
containing compounds, we found that the particular low field 
chemical shifts of the aromatic methoxy carbon signals at 
about 60 ppm (aromatic methoxy carbon signals were  
commonly at about 56 ppm), were without exception  
accompanied by o-substitutions on both sides of the methoxy 
groups.22 This observation may be explained by the steric  
hindrance of neighboring groups within the same plane.  
According to this regulation, the two methoxy groups (δH 3.83; δC 60.1/δH 4.03; δC 60.9) were assigned at C-3/C-6, since a  
chelated phenolic hydroxy group at δH 12.94 (1H, br. s) must 
be connected to C-5 and the two low field meta-coupled  
aromatic protons at δH 7.66 and 7.76 (each 1H, d, J = 1.7 Hz) 
can easily be assigned as H-2′/H-6′. This deduction was further 
supported by the HMBC correlations from δH 3.83 to C-3 (δC 
138.2) and from δH 4.03 to C-6 (δC 129.9). The HMBC  
correlations from the aromatic singlet at δH 6.55 to five  
quaternary carbons C-6, C-7, C-9, C-10, and C-4 (4J, ω-
coupled) indicated that the singlet was assigned to H-8.  
Accordingly, the hydroxy group leftover must be attached to 
C-7 (δC 154.8). On the basis of the above discussion, the struc-
ture of 1 was finally assigned as 2-[3,4-dihydro-3-hydroxy-8-
(3-methylbut-2-en-1-yl)-2,2-dimethyl-2H-1-benzopyran-6-yl]-
5,7-dihydroxy-3,6-dimethoxy-4H-1-benzopyran-4-one, and it 
was given the trivial name dodovisone A. 
Compound 2 was isolated as a yellowish powder with the 
molecular formula C27H32O9, as determined by HREIMS at 
m/z 500.2034 [M]+ (calcd 500.2046). The 1H and 13C NMR 
data (Table 1) of 2 indicated this compound to be an  
isoprenylated flavonoid, similar to 1. The only difference  
between them was the 3-methyl-2-butenyl group in 1 changing 
into a 4-hydroxy-3-methylbutyl group2 [δH 1.37, 1.60, 1.73, 
2.58, and 2.69 (each 1H, m), 3.37 (1H, dd, J = 10.6, 6.6 Hz), 
3.46 (1H, dd, J = 10.6, 5.9 Hz), and 0.99 (3H, d, J = 6.7 Hz); 
δC 28.8 (CH2), 34.6 (CH2), 36.2 (CH), 68.4 (CH2), and 17.1 
(CH3)] in 2. This group was confirmed by HMBC correlations 
from H-5′′′ to C-2′′′, C-3′′′, and C-4′′′, and from H-1′′′ to C-2′′′ 
and C-3′′′. The methylene protons (δH 2.69 and 2.58) of the 
isoprenoid side chain showed HMBC correlations to C-4′, C-5′, 
and C-6′, positioning this group at C-5′ as in 1. Hence, com-
pound 2 was elucidated as 2-[3,4-dihydro-3-hydroxy-8-(4-
hydroxy-3-methylbutyl)-2,2-dimethyl-2H-1-benzopyran-6-yl]-
5,7-dihydroxy-3,6-dimethoxy-4H-1-benzopyran-4-one, and it 
was given the name dodovisone B. 
Compound 3 gave a molecular formula of C27H30O8  
by HREIMS. Comparison of its 13C NMR data (Table 1)  
with those of 2 revealed similarities, except for the evident 
methine signals of a double bond (δC 122.1 and 130.8) in 3 
instead of a methylene (δC 32.3, C-1′′) and an oxygenated  
methane (δC 70.1, C-2′′) in 2, which was supported by HMBC 
correlations from H-1′′ (δH 6.39) to C-2′, C-3′, and C-4′ and 
from H-2′′ (δH 5.69) to C-3′, C-1′′, C-3′′, C-4′′, and C-5′′.  
Consequently, compound 3 was elucidated as 2-[8-(4-
hydroxy-3-methylbutyl)-2,2-dimethyl-2H-1-benzopyran-6-yl]-
5,7-dihydroxy-3,6-dimethoxy-4H-1-benzopyran-4-one and 
was named dodovisone C. 
Compound 4 was assigned the molecular formula C22H22O8 
by HREIMS. It was found to be an isoprenylated flavonol with 
the same ring A and C moieties as 1–3. The ABX spin system 
observed for aromatic protons in the 1H NMR (Table 1) at δH 
7.88 (1H, d, J = 2.2 Hz), 6.88 (1H, d, J = 8.5 Hz), and 7.82 
(1H, dd, J = 8.5, 2.2 Hz) suggested a 3′,4′-disubstitution  
pattern in ring B. A 2-hydroxy-3-methyl-3-butenyl unit2 was 
indicated by 1H NMR signals at δH 2.83 (1H, dd, J = 13.7, 7.8 
Hz), 2.96 (1H, dd, J = 13.7, 5.2 Hz), 4.39 (1H, dd, J = 7.8, 5.2 
Hz), 4.77 (1H, s), 4.87 (1H, s), and 1.81 (3H, s), and another 
hydroxy group was implied by the presence of an sp2  
quarternary carbon at δC 160.1. This butenyl unit was  
confirmed by HMBC correlations from H-5′′′ to C-2′′′, C-3′′′, 
and C-4′′′, and from H-1′′′ to C-2′′′ and C-3′′′. The above two 
groups were fixed at C-3′ and C-4′, respectively, by strong 
 
Figure 1.  Key HMBC correlations of 1 
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HMBC correlations, from a meta-coupled aromatic proton at 
δH 7.88 (1H, d, J = 2.2 Hz) to the methylene of the isoprenoid 
group at δC 38.1 and the oxygenated carbon at δC 160.1.  
Therefore, compound 4 was elucidated as 2-[3-(2-hydroxy- 
3-methylbut-3-en-1-yl)-4-hydroxyphenyl]-5,7-dihydroxy-3,6-
dimethoxy-4H-1-benzopyran-4-one and was named dodovi-
sone D. 
Compound 5 was isolated as colorless oil. Its molecular 
formula was determined as C18H26O4 from HREIMS at m/z 
306.1828 [M]+ (calcd 306.1831), requiring six degrees of  
unsaturation. The IR spectrum showed absorptions at 1773 and 
1737, which were attributed to two carbonyl groups. Analysis 
of the 13C NMR data (Table 2) revealed, in addition to a  
methoxy group at δC 51.6, a total of 17 signals consisting of 
two methyls, seven methylenes (one oxygenated), three  
methines (one olefinic), and five quarternary carbons (one 
olefinic and two carbonylic). The 1H and 13C NMR data (Table 
2) were in part close to those of mkapwanin,23 a butenolide-
containing clerodane diterpenoid from D. angustifolia.  
However, a methoxy signal and the molecular formula 
(C18H26O4) required a tri-norclerodane diterpenoid. The  
absence of signals for butenolide moiety and HMBC  
correlations (Figure 2) from H2-11, H2-12, and the methoxy 
protons to C-13 indicated that instead of a butenolide-
containing side chain, a methyl propionate one was linked at 
C-9; therefore, the planar structure of 5 was defined. 
The relative configuration of 5 was established by ROESY 
correlations and proton coupling constants based on computer-
generated 3D drawing with minimized energy by MM2  
calculation (Figure 2). The pro-19S diastereotopic proton, 
which was ω-coupled (4J = 2.0 Hz) with H-6β,23 showed  
correlations with H-1α and H3-20, indicating α- and axial  
orientation for both C-20 and C-19. In addition, the axially 
Table 1. NMR spectroscopic data for 1–4 
 
no. 
1a  2b 3a  4b 
H (J in Hz) C H (J in Hz) C H (J in Hz) C H (J in Hz) C 
2  156.6, C  158.1, C 156.4, C  158.4, C
3  138.2, C  139.2, C  138.2, C  139.2, C 
4  179.1, C  180.1, C  179.0, C  180.3, C 
5  151.7, C  153.6, Cc  151.7, C  153.7, Cc 
6  129.9, C  132.5, C  129.8, C  132.6, C 
7  154.8, C  158.6, C  154.8, C  158.7, C 
8 6.55, s 93.0, CH 6.44, s 95.0, CH 6.57, s 93.0, CH 6.48, s 95.0, CH 
9  152.2, C  153.7, Cc  152.1, C  153.8, Cc 
10  106.1, C  106.3, C  106.1, C  106.3, C 
1'  122.1, C  122.9, C  122.0, C  122.4, C 
2' 7.66, d (1.7) 128.2, CH 7.63, d (1.5) 129.3, CH 7.60, d (2.1) 124.6, CH 7.88, d (2.2) 133.1, CH 
3'  118.6, C  121.3, C  120.7, C  127.3, C 
4'  153.2, C  155.0, C  153.2, C  160.1, C 
5'  130.3, C  132.1, C  130.2, C 6.88, d (8.5) 116.3, CH 
6' 7.76, d (1.7) 128.0, CH 7.68, d (1.5) 129.1, CH 7.75, d (2.1) 130.0, CH 7.82, dd (8.5, 2.2) 129.5, CH 
1'' 3.16, dd (16.7, 4.8) 
2.87, dd (16.7, 5.5) 
31.5, CH2 3.07, dd (16.6, 5.2) 
2.78, dd (16.6, 7.5)
32.3, CH2 6.39, d (9.8) 122.1, CH 2.96, dd (13.7, 5.2) 
2.83, dd (13.7, 7.8)
38.1, CH2 
2'' 3.88, dd (5.5, 4.8) 69.4, CH 3.80, dd (7.5, 5.2) 70.1, CH 5.69, d (9.8) 130.8, CH 4.39, dd (7.8, 5.2) 76.4, CH 
3''  77.7, C  79.1, C  77.2, C  148.6, C 
4'' 1.41, s 22.4, CH3 1.30, s 21.3, CH3 1.48, s 28.3, CH3 4.77, s; 4.87, s 111.5, CH2 
5'' 1.36, s 25.1, CH3 1.39, s 26.1, CH3 1.48, s 28.3, CH3 1.81, s 18.1, CH3 
1''' 3.36, dd (15.5, 7.5) 
3.32, dd (15.5, 7.5) 
28.4, CH2 2.69, m; 2.58, m 28.8, CH2 2.63, m; 2.72, m 27.0, CH2   
2''' 5.31, t (7.5) 121.9, CH 1.73, m; 1.37, m 34.6, CH2 1.74, m; 1.45, m 33.1, CH2   
3'''  133.0, C 1.60, m 36.2, CH 1.71, m 35.2, CH   
4''' 1.74, s 17.9, CH3 3.46, dd (10.6, 5.9) 
3.37, dd (10.6, 6.6)
68.4, CH2 3.58, dd (10.5, 5.5) 
3.52, dd (10.5, 6.2)
68.1, CH2   
5''' 1.76, s 25.8, CH3 0.99, d (6.7) 17.1, CH3 1.03, d (6.5) 16.5, CH3   
3-OMe 3.83, s 60.1, CH3 3.73, s 60.5, CH3 3.84, s 60.1, CH3 3.75, s 60.6, CH3 
6-OMe 4.03, s 60.9, CH3 3.86, s 60.9, CH3 4.03, s 60.8, CH3 3.86, s 61.0, CH3 
5-OH 12.94, br. s    12.95, br. s    
aMeasured at 600 MHz in CDCl3. bMeasured at 500 MHz in CD3OD. cInterchangeable. 
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oriented proton H-6β at δH 1.13 (1H, dddd, 13.1, 13.1, 3.7, 2.0) 
showed correlations with H-8 and H-10, revealing β- and axial 
orientation for H-8 and H-10. Thus, compound 5 was finally 
established as shown and was named dodovislactone A. 
Compound 6 was isolated as an inseparable C-16 epimeric 
mixture (1:1) where some of the signals appeared as duplicate 
in the NMR spectra (Table 2). HREIMS gave a molecular 
formula of C21H30O5. Its NMR data indicated a clerodane 
diterpenoid similar to 16-hydroxycleroda-3,13-dien-16,15-
olide-18-oic acid,24 except that a methoxy group was evident 
in 6. HMBC correlation in 6 from the methoxy protons (δH 
3.57) to C-16 verified that the methoxy group was at C-16. In 
the ROESY spectrum, correlations of H3-19/H3-20 and  
H-10/H-12 revealed the orientation of C-19, C-20, and H-10 as 
α, α, and β, respectively. However, no useful information 
about the stereochemistry at C-8 was obtained. In consideration
of the co-occurrence of 5, 15-methoxypatagonic acid, 6α-
hydroxycleroda-3,13-dien-16,15-olid-18-oic acid, and hautri-
waic acid, C-8 should have the R* configuration of these  
analogues. This deduction was also supported by referring to 
the 1H and 13C NMR data of the diterpenoid hardwickiic acid25 
recorded in the same solvent. The diterpenoid was therefore 
elucidated as shown and was named dodovislactone B. 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Jasco P-1020 automatic digital polarimeter. UV 
spectra were obtained in an HPLC (Agilent 1200, DAD). IR 
 
Figure 2.  Key HMBC and ROESY correlations of 5 
Table 2. NMR spectroscopic dataa for 5 and 6 
 
no. 
5  6 
H (J in Hz) C H (J in Hz) C 
1 0.98, qd (12.5, 3.8) 19.2, CH2 1.47–1.63, overlap 17.36/17.37, CH2c 
1 1.59, m  1.47–1.63, overlap  
2 2.30, dddd (18.1, 7.4, 3.8, 1.9) 27.4, CH2b 2.13–2.37, overlap 27.3, CH2
2 2.07, dddd (18.1, 11.7, 4.8, 2.1)  2.13–2.37, overlap  
3 6.66, dd (7.4, 2.1) 136.2, CH 6.83, br. s 140.1, CH 
4  138.0, C  141.4, C 
5  45.3, C  37.5, C 
6 1.79, dt (13.1, 3.2) 34.1, CH2 2.42, br. d (12.0) 35.6, CH2 
6 1.13, dddd (13.1, 13.1, 3.7, 2.0)  1.15, br. t (11.5)  
7 1.39, m 27.3, CH2b 1.38–1.52, overlap 27.1, CH2 
7 1.54, m  1.38–1.52, overlap  
8 1.43, m 36.3, CH 1.47, overlap 36.22/36.27, CHc 
9  38.2, C  38.66/38.67, Cc 
10 1.50, d (12.4) 47.8, CH 1.29, d (12.0) 46.6, CH 
11 1.66, ddd (14.9, 12.2, 5.0) 32.0, CH2 1.51–1.68, overlap 34.7, CH2 
 1.59, m  1.51–1.68, overlap  
12 2.19, ddd (15.3, 12.3, 5.0) 27.7, CH2 2.17/2.34, mc 21.22/21.30, CH2c 
 1.95, ddd (15.3, 12.2, 4.9 )  2.03/2.17, mc  
13  174.4, C  168.05/168.14, Cc 
14   5.87, s 117.64/117.72, CHc 
15    170.65/170.67, Cc 
16   5.63/5.64, sb 104.31/104.39, CHc 
17 0.75, d (6.4) 15.1, CH3 0.81/0.82, d (5.6)b 15.9, CH3 
18  170.1, C  172.1, C 
19 pro-R 4.22, d (8.1) 71.9, CH2 1.25, s 20.4, CH3
 pro-S 3.84, dd (8.1, 2.0)    
20 0.52, s 17.1, CH3 0.79, s 18.19/18.22, CH3c 
OMe 3.58, s 51.6, CH3 3.57, s 57.03/57.16, CH3c 
aMeasured at 600 MHz in CDCl3. bInterchangeable. cDoubled signals due to epimer (1:1) at C-16. 
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spectra were obtained using a Bruker Tensor 27 FT-IR  
spectrometer with KBr pellets. The NMR spectra were  
acquired with an Avance III 600 or Bruker DRX-500  
instrument at room temperature. EIMS (including HREIMS) 
were measured on a VG-Auto-Spec-3000 spectrometer. 
ESIMS were measured on API QSTAR Pulsar i mass  
spectrometers. Silica gel (200–300 mesh, Qingdao Marine 
Chemical Inc., China) and Sephadex LH-20 (Amersham  
Biosciences, Sweden) were used for column chromatography. 
Fractions were monitored by TLC (Qingdao Marine Chemical 
Inc., China) in combination with reversed-phase HPLC  
(Agilent 1200, Extend-C18 column, 5 μm, 4.6 × 150 mm). 
Prep. HPLC was performed using an Agilent 1100 series 
(ZORBAX SB-C18 column, 5 μm, 9.4 × 150 mm for 10 
mL/min). Silica gel for prep. TLC was obtained from Qingdao 
Marine Chemical Inc., China. 
 
Plant Material. The aerial parts of D. viscosa were collected
from Yuanyang County in Yunnan Province, China, on May 
2011 and were identified by Prof. Yu Chen of Kunming  
Institute of Botany, Chinese Academy of Sciences. The 
voucher specimen was deposited at BioBioPha Co., Ltd. 
 
Extraction and Isolation. The aerial parts of D. viscosa  
(12 kg) was powdered and extracted with MeOH at room  
temperature. After filtration, the methanolic extract was  
evaporated under reduced pressure to get a residue (ca. 900 g), 
which was fractionized by silica gel column chromatography 
using petroleum ether (PE)/acetone gradient and then MeOH 
to yield six main fractions A–F. Separation of fraction C  
eluted with PE/acetone (9:1→7:3) by silica gel eluted with 
CHCl3/MeOH gave four subfractions C1 (100:1), C2 (30:1), 
C3 (20:1), and C4 (10:1). Fr. C1 was purified by Sephadex 
LH-20 (CHCl3/MeOH, 1:1) and then preparative TLC 
(PE/EtOAc, 9:1) to afford 5 (4 mg). Fraction C2 was purified 
by Sephadex LH-20 (CHCl3/MeOH, 1:1) and then preparative 
HPLC on a ZORBAX SB-C18 column (20%→100% CH3CN 
in H2O over 10 min) to afford 3 (4 mg, tR = 7.1 min) and 1 (2 
mg, tR = 7.6 min). Fraction C3 was purified by silica gel 
(CHCl3/MeOH, 20:1) and then Sephadex LH-20 (MeOH) to 
afford 2 (62 mg) and 4 (2 mg). Fraction D eluted by 
PE/acetone (6:4→1:1) was further separated by silica gel 
(CHCl3/MeOH, 50:1) into two subfractions - D1 and D2. After 
repeated preparative TLC (PE/EtOAc/formic acid, 40:10:0.2), 
fraction D1 afforded 6 (23 mg). 
 
Dodovisone A (1): yellowish powder; [α]18D   – 18.7 (c 0.13, 
CHCl3); UV (MeOH) max: 251, 271, 352 nm; IR (KBr) max 
3417, 2975, 2925, 2852, 1656, 1612, 1591, 1561, 1468, 1368, 
1308, 1209, 1170, 1139, 1093, 1049, 952 cm–1; 1H and 13C 
NMR data (see Table 1); EIMS: m/z 482 [M]+ (100), 467 (25), 
439 (10), 413 (12), 395 (11), 355 (12), 337 (6), 269 (8), 183 
(8), 105 (17); HREIMS: m/z 482.1960 [M]+ (calcd for 
C27H30O8, 482.1941). 
 
Dodovisone B (2): yellowish powder; [α]19D   – 3.8 (c 0.21, 
MeOH); UV (MeOH) max: 212, 251, 271, 353 nm; IR (KBr) 
max 3425, 2972, 2932, 2873, 1654, 1612, 1594, 1562, 1468, 
1369, 1307, 1266, 1210, 1171, 1139, 1092, 1048, 952 cm–1; 1H 
and 13C NMR data (see Table 1); ESIMS (pos.): m/z 523 [M + 
Na]+; HREIMS: m/z 500.2034 [M]+ (calcd for C27H32O9, 
500.2046). 
 
Dodovisone C (3): yellowish powder; [α]18D   – 53.3 (c 0.10, 
CHCl3); UV (MeOH) max: 216, 243, 272, 357 nm; IR (KBr) 
max 3416, 2960, 2927, 2854, 1654, 1611, 1562, 1467, 1378, 
1365, 1307, 1269, 1209, 1170, 1122, 1092, 1050, 954 cm–1; 1H 
and 13C NMR data (see Table 1); EIMS: m/z 482 [M]+ (71), 
467 (100), 449 (7), 409 (8), 395 (8), 234 (7), 197 (8), 175 (8), 
169 (5), 118 (4); HREIMS: m/z 482.1941 [M]+ (calcd for 
C27H30O8, 482.1941). 
 
Dodovisone D (4): yellowish powder; [α]19D   – 9.2 (c 0.20, 
MeOH); UV (MeOH) max: 248, 270, 349 nm; IR (KBr) max 
3423, 2933, 2851, 1654, 1610, 1563, 1470, 1366, 1280, 1208, 
1169, 1122, 1092, 1046, 997, 807 cm–1; 1H and 13C NMR data 
(see Table 1); EIMS: m/z 414 [M]+ (85), 399 (10), 381 (17), 
344 (70), 329 (33), 285 (10), 84 (77), 66 (100); HREIMS: m/z 
414.1345 [M]+ (calcd for C22H22O8, 414.1315). 
 
Dodovislactone A (5): colorless oil; [α]18D   – 96.3 (c 0.28, 
CHCl3); UV (MeOH) max: 240 (sh) nm; IR (KBr) max 2957, 
2927, 2874, 1773, 1737, 1452, 1437, 1286, 1198, 1189, 1122, 
1038, 1005, 988 cm–1; 1H and 13C NMR data (see Table 2); 
ESIMS (pos.): m/z 329 [M + Na]+; HREIMS: m/z 306.1828 
[M]+ (calcd for C18H26O4, 306.1831). 
 
Dodovislactone B (6): colorless oil; [α]19D   – 72.8 (c 0.20, 
CHCl3); UV (MeOH) max: 212 nm; IR (KBr) max 3440, 2960, 
2923, 2862, 1796, 1765, 1711, 1680, 1648, 1629, 1457, 1420, 
1382, 1263, 1204, 1172, 1118, 962, 939 cm–1; 1H and 13C 
NMR data (see Table 2); ESIMS (pos.): m/z 385 [M + Na]+; 
HREIMS: m/z 362.2097 [M]+ (calcd for C21H30O5, 362.2093). 
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